May 15, 2018 / 8:25 PM / 3 months ago

BRIEF-Eleven Biotherapeutics Q1 Loss Per Share $0.11

May 15 (Reuters) - Eleven Biotherapeutics Inc:

* ELEVEN BIOTHERAPEUTICS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PIPELINE UPDATES

* Q1 LOSS PER SHARE $0.11

* THERE WAS NO REVENUE FOR QUARTER ENDED MARCH 31, 2018, COMPARED TO $0.4 MILLION FOR SAME PERIOD IN 2017

* ELEVEN BIOTHERAPEUTICS -REVENUE FALL DUE TO REDUCTION IN REVENUE RECOGNIZED FROM CO’S LICENSE AGREEMENT WITH F. HOFFMANN-LA ROCHE LTD, HOFFMANN-LA ROCHE INC

* COMPANY MAINTAINS IT WILL HAVE CAPITAL TO FUND ITS CURRENT OPERATING PLANS INTO EARLY 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below